{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "8395bbae",
   "metadata": {},
   "outputs": [],
   "source": [
    "from selenium import webdriver\n",
    "from selenium.webdriver.chrome.service import Service\n",
    "from selenium.webdriver.common.by import By\n",
    "import pandas as pd\n",
    "import urls\n",
    "import random"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "132fc44d",
   "metadata": {},
   "outputs": [],
   "source": [
    "stocks = {'sava':0,\n",
    "          'surf':1,\n",
    "          'crdf':2,\n",
    "          'avxl':3}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "b74642a4",
   "metadata": {},
   "outputs": [],
   "source": [
    "def extract_topic():\n",
    "    \n",
    "    df = pd.DataFrame(columns=['Stock', 'Sep 2020', 'Oct 2020', 'Nov 2020', 'Dec 2020', 'Jan 2021', 'Feb 2021',\n",
    "                           'Mar 2021', 'Apr 2021', 'May 2021', 'Jun 2021', 'Jul 2021', 'Aug 2021', 'Sep 2021'])\n",
    "    \n",
    "    for key in stocks.keys():\n",
    "        print(\"Executing for stock: \", key)\n",
    "        url_list = urls.url_dict[key]\n",
    "\n",
    "        df = pd.concat([df, pd.DataFrame({}, index=[stocks.get(key)], columns=df.columns)])\n",
    "        df.iloc[stocks.get(key), 0] = key\n",
    "\n",
    "        service = Service('path/to/chromedriver')\n",
    "        driver = webdriver.Chrome(service=service)\n",
    "\n",
    "        for i, url in enumerate(url_list):\n",
    "            if url!=\"NA\":\n",
    "                driver.get(url)\n",
    "                driver.implicitly_wait(random.randint(15, 20))\n",
    "\n",
    "                text = \"\"\n",
    "                paragraphs = driver.find_elements(By.CLASS_NAME, 'press-release-header__title')\n",
    "                for p in paragraphs:\n",
    "                    text += p.text\n",
    "            else:\n",
    "                text = \"Neutral\"\n",
    "            df.iloc[stocks.get(key), i+1] = text\n",
    "            print(\"Extracted text for \", df.columns[i+1])\n",
    "\n",
    "        driver.quit()\n",
    "        print(\"Shape of data after this iteration: \", df.shape ,\"\\n\")\n",
    "        \n",
    "    df.columns = [f'{col}_topic' if i >= 0 else col for i, col in enumerate(df.columns)]\n",
    "        \n",
    "    return df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "06d83f7f",
   "metadata": {},
   "outputs": [],
   "source": [
    "def extract_content():\n",
    "    \n",
    "    df = pd.DataFrame(columns=['Stock', 'Sep 2020', 'Oct 2020', 'Nov 2020', 'Dec 2020', 'Jan 2021', 'Feb 2021',\n",
    "                           'Mar 2021', 'Apr 2021', 'May 2021', 'Jun 2021', 'Jul 2021', 'Aug 2021', 'Sep 2021'])\n",
    "    \n",
    "    for key in stocks.keys():\n",
    "        print(\"Executing for stock: \", key)\n",
    "        url_list = urls.url_dict[key]\n",
    "\n",
    "        df = pd.concat([df, pd.DataFrame({}, index=[stocks.get(key)], columns=df.columns)])\n",
    "        df.iloc[stocks.get(key), 0] = key\n",
    "\n",
    "        service = Service('path/to/chromedriver')\n",
    "        driver = webdriver.Chrome(service=service)\n",
    "\n",
    "        for i, url in enumerate(url_list):\n",
    "            if url!=\"NA\":\n",
    "                driver.get(url)\n",
    "                driver.implicitly_wait(random.randint(20, 25))\n",
    "                text = \"\"\n",
    "                paragraphs = driver.find_elements(By.TAG_NAME, 'p')\n",
    "                for p in paragraphs:\n",
    "                    text += p.text\n",
    "            else:\n",
    "                text = \"Neutral\"\n",
    "            df.iloc[stocks.get(key), i+1] = text\n",
    "            print(\"Extracted text for \", df.columns[i+1])\n",
    "\n",
    "        driver.quit()\n",
    "        print(\"Shape of data after this iteration: \", df.shape ,\"\\n\")\n",
    "        \n",
    "    df.columns = [f'{col}_content' if i > 0 else col for i, col in enumerate(df.columns)]\n",
    "        \n",
    "    return df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "b87f6c6f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Executing for stock:  sava\n",
      "Extracted text for  Sep 2020\n",
      "Extracted text for  Oct 2020\n",
      "Extracted text for  Nov 2020\n",
      "Extracted text for  Dec 2020\n",
      "Extracted text for  Jan 2021\n",
      "Extracted text for  Feb 2021\n",
      "Extracted text for  Mar 2021\n",
      "Extracted text for  Apr 2021\n",
      "Extracted text for  May 2021\n",
      "Extracted text for  Jun 2021\n",
      "Extracted text for  Jul 2021\n",
      "Extracted text for  Aug 2021\n",
      "Extracted text for  Sep 2021\n",
      "Shape of data after this iteration:  (1, 14) \n",
      "\n",
      "Executing for stock:  surf\n",
      "Extracted text for  Sep 2020\n",
      "Extracted text for  Oct 2020\n",
      "Extracted text for  Nov 2020\n",
      "Extracted text for  Dec 2020\n",
      "Extracted text for  Jan 2021\n",
      "Extracted text for  Feb 2021\n",
      "Extracted text for  Mar 2021\n",
      "Extracted text for  Apr 2021\n",
      "Extracted text for  May 2021\n",
      "Extracted text for  Jun 2021\n",
      "Extracted text for  Jul 2021\n",
      "Extracted text for  Aug 2021\n",
      "Extracted text for  Sep 2021\n",
      "Shape of data after this iteration:  (2, 14) \n",
      "\n",
      "Executing for stock:  crdf\n",
      "Extracted text for  Sep 2020\n",
      "Extracted text for  Oct 2020\n",
      "Extracted text for  Nov 2020\n",
      "Extracted text for  Dec 2020\n",
      "Extracted text for  Jan 2021\n",
      "Extracted text for  Feb 2021\n",
      "Extracted text for  Mar 2021\n",
      "Extracted text for  Apr 2021\n",
      "Extracted text for  May 2021\n",
      "Extracted text for  Jun 2021\n",
      "Extracted text for  Jul 2021\n",
      "Extracted text for  Aug 2021\n",
      "Extracted text for  Sep 2021\n",
      "Shape of data after this iteration:  (3, 14) \n",
      "\n",
      "Executing for stock:  avxl\n",
      "Extracted text for  Sep 2020\n",
      "Extracted text for  Oct 2020\n",
      "Extracted text for  Nov 2020\n",
      "Extracted text for  Dec 2020\n",
      "Extracted text for  Jan 2021\n",
      "Extracted text for  Feb 2021\n",
      "Extracted text for  Mar 2021\n",
      "Extracted text for  Apr 2021\n",
      "Extracted text for  May 2021\n",
      "Extracted text for  Jun 2021\n",
      "Extracted text for  Jul 2021\n",
      "Extracted text for  Aug 2021\n",
      "Extracted text for  Sep 2021\n",
      "Shape of data after this iteration:  (4, 14) \n",
      "\n"
     ]
    }
   ],
   "source": [
    "df_topic = extract_topic()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "568a92be",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Executing for stock:  sava\n",
      "Extracted text for  Sep 2020\n",
      "Extracted text for  Oct 2020\n",
      "Extracted text for  Nov 2020\n",
      "Extracted text for  Dec 2020\n",
      "Extracted text for  Jan 2021\n",
      "Extracted text for  Feb 2021\n",
      "Extracted text for  Mar 2021\n",
      "Extracted text for  Apr 2021\n",
      "Extracted text for  May 2021\n",
      "Extracted text for  Jun 2021\n",
      "Extracted text for  Jul 2021\n",
      "Extracted text for  Aug 2021\n",
      "Extracted text for  Sep 2021\n",
      "Shape of data after this iteration:  (1, 14) \n",
      "\n",
      "Executing for stock:  surf\n",
      "Extracted text for  Sep 2020\n",
      "Extracted text for  Oct 2020\n",
      "Extracted text for  Nov 2020\n",
      "Extracted text for  Dec 2020\n",
      "Extracted text for  Jan 2021\n",
      "Extracted text for  Feb 2021\n",
      "Extracted text for  Mar 2021\n",
      "Extracted text for  Apr 2021\n",
      "Extracted text for  May 2021\n",
      "Extracted text for  Jun 2021\n",
      "Extracted text for  Jul 2021\n",
      "Extracted text for  Aug 2021\n",
      "Extracted text for  Sep 2021\n",
      "Shape of data after this iteration:  (2, 14) \n",
      "\n",
      "Executing for stock:  crdf\n",
      "Extracted text for  Sep 2020\n",
      "Extracted text for  Oct 2020\n",
      "Extracted text for  Nov 2020\n",
      "Extracted text for  Dec 2020\n",
      "Extracted text for  Jan 2021\n",
      "Extracted text for  Feb 2021\n",
      "Extracted text for  Mar 2021\n",
      "Extracted text for  Apr 2021\n",
      "Extracted text for  May 2021\n",
      "Extracted text for  Jun 2021\n",
      "Extracted text for  Jul 2021\n",
      "Extracted text for  Aug 2021\n",
      "Extracted text for  Sep 2021\n",
      "Shape of data after this iteration:  (3, 14) \n",
      "\n",
      "Executing for stock:  avxl\n",
      "Extracted text for  Sep 2020\n",
      "Extracted text for  Oct 2020\n",
      "Extracted text for  Nov 2020\n",
      "Extracted text for  Dec 2020\n",
      "Extracted text for  Jan 2021\n",
      "Extracted text for  Feb 2021\n",
      "Extracted text for  Mar 2021\n",
      "Extracted text for  Apr 2021\n",
      "Extracted text for  May 2021\n",
      "Extracted text for  Jun 2021\n",
      "Extracted text for  Jul 2021\n",
      "Extracted text for  Aug 2021\n",
      "Extracted text for  Sep 2021\n",
      "Shape of data after this iteration:  (4, 14) \n",
      "\n"
     ]
    }
   ],
   "source": [
    "df_content = extract_content()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "c69b9df4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Stock</th>\n",
       "      <th>Sep 2020_topic</th>\n",
       "      <th>Oct 2020_topic</th>\n",
       "      <th>Nov 2020_topic</th>\n",
       "      <th>Dec 2020_topic</th>\n",
       "      <th>Jan 2021_topic</th>\n",
       "      <th>Feb 2021_topic</th>\n",
       "      <th>Mar 2021_topic</th>\n",
       "      <th>Apr 2021_topic</th>\n",
       "      <th>May 2021_topic</th>\n",
       "      <th>Jun 2021_topic</th>\n",
       "      <th>Jul 2021_topic</th>\n",
       "      <th>Aug 2021_topic</th>\n",
       "      <th>Sep 2021_topic</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>sava</td>\n",
       "      <td>Cassava Sciences Announces Final Results of a ...</td>\n",
       "      <td>Neutral</td>\n",
       "      <td>USAN Modifies Lead Drug Candidate’s Chemical N...</td>\n",
       "      <td>Neutral</td>\n",
       "      <td>Cassava Sciences Appoints Dr. James Kupiec as ...</td>\n",
       "      <td>Cassava Sciences’ Simufilam Improves Cognition...</td>\n",
       "      <td>Cassava Sciences to Present at the H.C. Wainwr...</td>\n",
       "      <td>Cassava Sciences Invited by the NIH to Partici...</td>\n",
       "      <td>Cassava Sciences Announces Initiation of Cogni...</td>\n",
       "      <td>Cassava Sciences to Present at the Raymond Jam...</td>\n",
       "      <td>Cassava Sciences Announces Positive Data with ...</td>\n",
       "      <td>Cassava Sciences Reports Second Quarter 2021 F...</td>\n",
       "      <td>Cassava Sciences to Present at H.C. Wainwright...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>surf</td>\n",
       "      <td>Surface Oncology to Participate in the H.C. Wa...</td>\n",
       "      <td>Surface Oncology to Report SRF388 Preclinical ...</td>\n",
       "      <td>Surface Oncology Announces SRF617 and SRF388 W...</td>\n",
       "      <td>Surface Oncology Announces Exclusive License A...</td>\n",
       "      <td>Surface Oncology to Participate in H.C. Wainwr...</td>\n",
       "      <td>Surface Oncology to Appoint Robert Ross, M.D.,...</td>\n",
       "      <td>Surface Oncology to Collaborate with Merck on ...</td>\n",
       "      <td>Surface Oncology Presents Promising Preclinica...</td>\n",
       "      <td>Surface Oncology Reports Financial Results and...</td>\n",
       "      <td>SRF388, a First-in-Class IL-27 Antibody, Demon...</td>\n",
       "      <td>Surface Oncology Appoints Denice Torres to Boa...</td>\n",
       "      <td>Surface Oncology Reports Financial Results and...</td>\n",
       "      <td>Neutral</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>crdf</td>\n",
       "      <td>Cardiff Oncology to Present Data Further Demon...</td>\n",
       "      <td>Cardiff Oncology Presents Positive Efficacy an...</td>\n",
       "      <td>Cardiff Oncology Announces Third Quarter 2020 ...</td>\n",
       "      <td>Cardiff Oncology Presents Data at ASH Demonstr...</td>\n",
       "      <td>Cardiff Oncology Presents Data that Continues ...</td>\n",
       "      <td>Cardiff Oncology Presents Phase 2 mCRPC Trial ...</td>\n",
       "      <td>Cardiff Oncology to Present at the Oppenheimer...</td>\n",
       "      <td>Cardiff Oncology Announces Onvansertib Phase 1...</td>\n",
       "      <td>Cardiff Oncology to Present at the Jefferies V...</td>\n",
       "      <td>Cardiff Oncology Announces First Patient Dosed...</td>\n",
       "      <td>Cardiff Oncology Announces the Appointments of...</td>\n",
       "      <td>Cardiff Oncology to Present New Data from Lead...</td>\n",
       "      <td>Cardiff Oncology Announces New Data from Phase...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>avxl</td>\n",
       "      <td>Anavex Life Sciences Announces Completion of A...</td>\n",
       "      <td>Anavex Life Sciences Announces Positive Result...</td>\n",
       "      <td>Proof of Concept Controlled Phase 2 Clinical T...</td>\n",
       "      <td>Anavex Life Sciences Announces ANAVEX®2-73 (Bl...</td>\n",
       "      <td>Anavex Life Sciences Receives Michael J. Fox F...</td>\n",
       "      <td>Anavex Life Sciences Reports Fiscal 2021 First...</td>\n",
       "      <td>Anavex Life Sciences Reports ANAVEX®2-73 (blar...</td>\n",
       "      <td>Anavex Life Sciences Reports the Results of Re...</td>\n",
       "      <td>Anavex Life Sciences Announces Participation a...</td>\n",
       "      <td>Anavex Life Sciences Announces ANAVEX®2-73 (Bl...</td>\n",
       "      <td>Anavex Life Sciences Announces ANAVEX®2-73 (Bl...</td>\n",
       "      <td>Anavex Life Sciences Provides Business Update ...</td>\n",
       "      <td>Anavex Life Sciences to Present at the H.C. Wa...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  Stock                                     Sep 2020_topic  \\\n",
       "0  sava  Cassava Sciences Announces Final Results of a ...   \n",
       "1  surf  Surface Oncology to Participate in the H.C. Wa...   \n",
       "2  crdf  Cardiff Oncology to Present Data Further Demon...   \n",
       "3  avxl  Anavex Life Sciences Announces Completion of A...   \n",
       "\n",
       "                                      Oct 2020_topic  \\\n",
       "0                                            Neutral   \n",
       "1  Surface Oncology to Report SRF388 Preclinical ...   \n",
       "2  Cardiff Oncology Presents Positive Efficacy an...   \n",
       "3  Anavex Life Sciences Announces Positive Result...   \n",
       "\n",
       "                                      Nov 2020_topic  \\\n",
       "0  USAN Modifies Lead Drug Candidate’s Chemical N...   \n",
       "1  Surface Oncology Announces SRF617 and SRF388 W...   \n",
       "2  Cardiff Oncology Announces Third Quarter 2020 ...   \n",
       "3  Proof of Concept Controlled Phase 2 Clinical T...   \n",
       "\n",
       "                                      Dec 2020_topic  \\\n",
       "0                                            Neutral   \n",
       "1  Surface Oncology Announces Exclusive License A...   \n",
       "2  Cardiff Oncology Presents Data at ASH Demonstr...   \n",
       "3  Anavex Life Sciences Announces ANAVEX®2-73 (Bl...   \n",
       "\n",
       "                                      Jan 2021_topic  \\\n",
       "0  Cassava Sciences Appoints Dr. James Kupiec as ...   \n",
       "1  Surface Oncology to Participate in H.C. Wainwr...   \n",
       "2  Cardiff Oncology Presents Data that Continues ...   \n",
       "3  Anavex Life Sciences Receives Michael J. Fox F...   \n",
       "\n",
       "                                      Feb 2021_topic  \\\n",
       "0  Cassava Sciences’ Simufilam Improves Cognition...   \n",
       "1  Surface Oncology to Appoint Robert Ross, M.D.,...   \n",
       "2  Cardiff Oncology Presents Phase 2 mCRPC Trial ...   \n",
       "3  Anavex Life Sciences Reports Fiscal 2021 First...   \n",
       "\n",
       "                                      Mar 2021_topic  \\\n",
       "0  Cassava Sciences to Present at the H.C. Wainwr...   \n",
       "1  Surface Oncology to Collaborate with Merck on ...   \n",
       "2  Cardiff Oncology to Present at the Oppenheimer...   \n",
       "3  Anavex Life Sciences Reports ANAVEX®2-73 (blar...   \n",
       "\n",
       "                                      Apr 2021_topic  \\\n",
       "0  Cassava Sciences Invited by the NIH to Partici...   \n",
       "1  Surface Oncology Presents Promising Preclinica...   \n",
       "2  Cardiff Oncology Announces Onvansertib Phase 1...   \n",
       "3  Anavex Life Sciences Reports the Results of Re...   \n",
       "\n",
       "                                      May 2021_topic  \\\n",
       "0  Cassava Sciences Announces Initiation of Cogni...   \n",
       "1  Surface Oncology Reports Financial Results and...   \n",
       "2  Cardiff Oncology to Present at the Jefferies V...   \n",
       "3  Anavex Life Sciences Announces Participation a...   \n",
       "\n",
       "                                      Jun 2021_topic  \\\n",
       "0  Cassava Sciences to Present at the Raymond Jam...   \n",
       "1  SRF388, a First-in-Class IL-27 Antibody, Demon...   \n",
       "2  Cardiff Oncology Announces First Patient Dosed...   \n",
       "3  Anavex Life Sciences Announces ANAVEX®2-73 (Bl...   \n",
       "\n",
       "                                      Jul 2021_topic  \\\n",
       "0  Cassava Sciences Announces Positive Data with ...   \n",
       "1  Surface Oncology Appoints Denice Torres to Boa...   \n",
       "2  Cardiff Oncology Announces the Appointments of...   \n",
       "3  Anavex Life Sciences Announces ANAVEX®2-73 (Bl...   \n",
       "\n",
       "                                      Aug 2021_topic  \\\n",
       "0  Cassava Sciences Reports Second Quarter 2021 F...   \n",
       "1  Surface Oncology Reports Financial Results and...   \n",
       "2  Cardiff Oncology to Present New Data from Lead...   \n",
       "3  Anavex Life Sciences Provides Business Update ...   \n",
       "\n",
       "                                      Sep 2021_topic  \n",
       "0  Cassava Sciences to Present at H.C. Wainwright...  \n",
       "1                                            Neutral  \n",
       "2  Cardiff Oncology Announces New Data from Phase...  \n",
       "3  Anavex Life Sciences to Present at the H.C. Wa...  "
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_topic.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "39eaa7db",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Stock</th>\n",
       "      <th>Sep 2020_content</th>\n",
       "      <th>Oct 2020_content</th>\n",
       "      <th>Nov 2020_content</th>\n",
       "      <th>Dec 2020_content</th>\n",
       "      <th>Jan 2021_content</th>\n",
       "      <th>Feb 2021_content</th>\n",
       "      <th>Mar 2021_content</th>\n",
       "      <th>Apr 2021_content</th>\n",
       "      <th>May 2021_content</th>\n",
       "      <th>Jun 2021_content</th>\n",
       "      <th>Jul 2021_content</th>\n",
       "      <th>Aug 2021_content</th>\n",
       "      <th>Sep 2021_content</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>sava</td>\n",
       "      <td>Alzheimer’s Patients in Drug Groups Showed Sta...</td>\n",
       "      <td>Neutral</td>\n",
       "      <td>AUSTIN, Texas, Nov. 27, 2020 (GLOBE NEWSWIRE) ...</td>\n",
       "      <td>Neutral</td>\n",
       "      <td>AUSTIN, Texas, Jan. 04, 2021 (GLOBE NEWSWIRE) ...</td>\n",
       "      <td>- Patients’ Cognition Improved 1.6 Points on A...</td>\n",
       "      <td>AUSTIN, Texas, March 08, 2021 (GLOBE NEWSWIRE)...</td>\n",
       "      <td>AUSTIN, Texas, April 26, 2021 (GLOBE NEWSWIRE)...</td>\n",
       "      <td>- Randomized, Controlled Study is Designed to ...</td>\n",
       "      <td>AUSTIN, Texas, June 17, 2021 (GLOBE NEWSWIRE) ...</td>\n",
       "      <td>AUSTIN, Texas, July 26, 2021 (GLOBE NEWSWIRE) ...</td>\n",
       "      <td>AUSTIN, Texas, Aug. 03, 2021 (GLOBE NEWSWIRE) ...</td>\n",
       "      <td>AUSTIN, Texas, Sept. 09, 2021 (GLOBE NEWSWIRE)...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>surf</td>\n",
       "      <td>CAMBRIDGE, Mass., Sept. 11, 2020 (GLOBE NEWSWI...</td>\n",
       "      <td>CAMBRIDGE, Mass., Oct. 26, 2020 (GLOBE NEWSWIR...</td>\n",
       "      <td>Both programs have successfully escalated to d...</td>\n",
       "      <td>GSK will have exclusive rights to develop and ...</td>\n",
       "      <td>CAMBRIDGE, Mass., Jan. 11, 2021 (GLOBE NEWSWIR...</td>\n",
       "      <td>Experienced clinical development executive to ...</td>\n",
       "      <td>CAMBRIDGE, Mass., March 09, 2021 (GLOBE NEWSWI...</td>\n",
       "      <td>CAMBRIDGE, Mass., April 09, 2021 (GLOBE NEWSWI...</td>\n",
       "      <td>CAMBRIDGE, Mass., May 05, 2021 (GLOBE NEWSWIRE...</td>\n",
       "      <td>Preliminary Data for SRF617 Show Good Tolerabi...</td>\n",
       "      <td>CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIR...</td>\n",
       "      <td>SRF388, a First-in-Class Anti-IL-27 Antibody, ...</td>\n",
       "      <td>Neutral</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>crdf</td>\n",
       "      <td>SAN DIEGO, Sept. 14, 2020 /PRNewswire/ -- Card...</td>\n",
       "      <td>SAN DIEGO, Oct. 20, 2020 /PRNewswire/ -- Cardi...</td>\n",
       "      <td>SAN DIEGO, Nov. 5, 2020 /PRNewswire/ -- Cardif...</td>\n",
       "      <td>SAN DIEGO, Dec. 6, 2020 /PRNewswire/ -- Cardif...</td>\n",
       "      <td>SAN DIEGO, Jan. 15, 2021 /PRNewswire/ -- Cardi...</td>\n",
       "      <td>SAN DIEGO, Feb. 11, 2021 /PRNewswire/ -- Cardi...</td>\n",
       "      <td>SAN DIEGO, March 11, 2021 /PRNewswire/ -- Card...</td>\n",
       "      <td>SAN DIEGO, April 12, 2021 /PRNewswire/ -- Card...</td>\n",
       "      <td>SAN DIEGO, May 20, 2021 /PRNewswire/ -- Cardif...</td>\n",
       "      <td>SAN DIEGO, June 8, 2021 /PRNewswire/ -- Cardif...</td>\n",
       "      <td>SAN DIEGO, July 12, 2021 /PRNewswire/ -- Cardi...</td>\n",
       "      <td>SAN DIEGO, Aug. 25, 2021 /PRNewswire/ -- Cardi...</td>\n",
       "      <td>SAN DIEGO, Sept. 8, 2021 /PRNewswire/ -- Cardi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>avxl</td>\n",
       "      <td>NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- A...</td>\n",
       "      <td>Clinically meaningful, dose-dependent, and sta...</td>\n",
       "      <td>Statistically significant improvements in CDR ...</td>\n",
       "      <td>Primary safety, pharmacokinetics and secondary...</td>\n",
       "      <td>NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- An...</td>\n",
       "      <td>NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- An...</td>\n",
       "      <td>NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- A...</td>\n",
       "      <td>NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) -- A...</td>\n",
       "      <td>NEW YORK, May 07, 2021 (GLOBE NEWSWIRE) -- Ana...</td>\n",
       "      <td>ANAVEX®2-73 treatment resulted in significant ...</td>\n",
       "      <td>Pre-Treatment with ANAVEX®2-73 entirely preven...</td>\n",
       "      <td>NEW YORK, Aug. 12, 2021 (GLOBE NEWSWIRE) -- An...</td>\n",
       "      <td>NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- A...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  Stock                                   Sep 2020_content  \\\n",
       "0  sava  Alzheimer’s Patients in Drug Groups Showed Sta...   \n",
       "1  surf  CAMBRIDGE, Mass., Sept. 11, 2020 (GLOBE NEWSWI...   \n",
       "2  crdf  SAN DIEGO, Sept. 14, 2020 /PRNewswire/ -- Card...   \n",
       "3  avxl  NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- A...   \n",
       "\n",
       "                                    Oct 2020_content  \\\n",
       "0                                            Neutral   \n",
       "1  CAMBRIDGE, Mass., Oct. 26, 2020 (GLOBE NEWSWIR...   \n",
       "2  SAN DIEGO, Oct. 20, 2020 /PRNewswire/ -- Cardi...   \n",
       "3  Clinically meaningful, dose-dependent, and sta...   \n",
       "\n",
       "                                    Nov 2020_content  \\\n",
       "0  AUSTIN, Texas, Nov. 27, 2020 (GLOBE NEWSWIRE) ...   \n",
       "1  Both programs have successfully escalated to d...   \n",
       "2  SAN DIEGO, Nov. 5, 2020 /PRNewswire/ -- Cardif...   \n",
       "3  Statistically significant improvements in CDR ...   \n",
       "\n",
       "                                    Dec 2020_content  \\\n",
       "0                                            Neutral   \n",
       "1  GSK will have exclusive rights to develop and ...   \n",
       "2  SAN DIEGO, Dec. 6, 2020 /PRNewswire/ -- Cardif...   \n",
       "3  Primary safety, pharmacokinetics and secondary...   \n",
       "\n",
       "                                    Jan 2021_content  \\\n",
       "0  AUSTIN, Texas, Jan. 04, 2021 (GLOBE NEWSWIRE) ...   \n",
       "1  CAMBRIDGE, Mass., Jan. 11, 2021 (GLOBE NEWSWIR...   \n",
       "2  SAN DIEGO, Jan. 15, 2021 /PRNewswire/ -- Cardi...   \n",
       "3  NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- An...   \n",
       "\n",
       "                                    Feb 2021_content  \\\n",
       "0  - Patients’ Cognition Improved 1.6 Points on A...   \n",
       "1  Experienced clinical development executive to ...   \n",
       "2  SAN DIEGO, Feb. 11, 2021 /PRNewswire/ -- Cardi...   \n",
       "3  NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- An...   \n",
       "\n",
       "                                    Mar 2021_content  \\\n",
       "0  AUSTIN, Texas, March 08, 2021 (GLOBE NEWSWIRE)...   \n",
       "1  CAMBRIDGE, Mass., March 09, 2021 (GLOBE NEWSWI...   \n",
       "2  SAN DIEGO, March 11, 2021 /PRNewswire/ -- Card...   \n",
       "3  NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- A...   \n",
       "\n",
       "                                    Apr 2021_content  \\\n",
       "0  AUSTIN, Texas, April 26, 2021 (GLOBE NEWSWIRE)...   \n",
       "1  CAMBRIDGE, Mass., April 09, 2021 (GLOBE NEWSWI...   \n",
       "2  SAN DIEGO, April 12, 2021 /PRNewswire/ -- Card...   \n",
       "3  NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) -- A...   \n",
       "\n",
       "                                    May 2021_content  \\\n",
       "0  - Randomized, Controlled Study is Designed to ...   \n",
       "1  CAMBRIDGE, Mass., May 05, 2021 (GLOBE NEWSWIRE...   \n",
       "2  SAN DIEGO, May 20, 2021 /PRNewswire/ -- Cardif...   \n",
       "3  NEW YORK, May 07, 2021 (GLOBE NEWSWIRE) -- Ana...   \n",
       "\n",
       "                                    Jun 2021_content  \\\n",
       "0  AUSTIN, Texas, June 17, 2021 (GLOBE NEWSWIRE) ...   \n",
       "1  Preliminary Data for SRF617 Show Good Tolerabi...   \n",
       "2  SAN DIEGO, June 8, 2021 /PRNewswire/ -- Cardif...   \n",
       "3  ANAVEX®2-73 treatment resulted in significant ...   \n",
       "\n",
       "                                    Jul 2021_content  \\\n",
       "0  AUSTIN, Texas, July 26, 2021 (GLOBE NEWSWIRE) ...   \n",
       "1  CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIR...   \n",
       "2  SAN DIEGO, July 12, 2021 /PRNewswire/ -- Cardi...   \n",
       "3  Pre-Treatment with ANAVEX®2-73 entirely preven...   \n",
       "\n",
       "                                    Aug 2021_content  \\\n",
       "0  AUSTIN, Texas, Aug. 03, 2021 (GLOBE NEWSWIRE) ...   \n",
       "1  SRF388, a First-in-Class Anti-IL-27 Antibody, ...   \n",
       "2  SAN DIEGO, Aug. 25, 2021 /PRNewswire/ -- Cardi...   \n",
       "3  NEW YORK, Aug. 12, 2021 (GLOBE NEWSWIRE) -- An...   \n",
       "\n",
       "                                    Sep 2021_content  \n",
       "0  AUSTIN, Texas, Sept. 09, 2021 (GLOBE NEWSWIRE)...  \n",
       "1                                            Neutral  \n",
       "2  SAN DIEGO, Sept. 8, 2021 /PRNewswire/ -- Cardi...  \n",
       "3  NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- A...  "
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_content.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "081b975b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Stock</th>\n",
       "      <th>Sep 2020_topic</th>\n",
       "      <th>Oct 2020_topic</th>\n",
       "      <th>Nov 2020_topic</th>\n",
       "      <th>Dec 2020_topic</th>\n",
       "      <th>Jan 2021_topic</th>\n",
       "      <th>Feb 2021_topic</th>\n",
       "      <th>Mar 2021_topic</th>\n",
       "      <th>Apr 2021_topic</th>\n",
       "      <th>May 2021_topic</th>\n",
       "      <th>...</th>\n",
       "      <th>Dec 2020_content</th>\n",
       "      <th>Jan 2021_content</th>\n",
       "      <th>Feb 2021_content</th>\n",
       "      <th>Mar 2021_content</th>\n",
       "      <th>Apr 2021_content</th>\n",
       "      <th>May 2021_content</th>\n",
       "      <th>Jun 2021_content</th>\n",
       "      <th>Jul 2021_content</th>\n",
       "      <th>Aug 2021_content</th>\n",
       "      <th>Sep 2021_content</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>sava</td>\n",
       "      <td>Cassava Sciences Announces Final Results of a ...</td>\n",
       "      <td>Neutral</td>\n",
       "      <td>USAN Modifies Lead Drug Candidate’s Chemical N...</td>\n",
       "      <td>Neutral</td>\n",
       "      <td>Cassava Sciences Appoints Dr. James Kupiec as ...</td>\n",
       "      <td>Cassava Sciences’ Simufilam Improves Cognition...</td>\n",
       "      <td>Cassava Sciences to Present at the H.C. Wainwr...</td>\n",
       "      <td>Cassava Sciences Invited by the NIH to Partici...</td>\n",
       "      <td>Cassava Sciences Announces Initiation of Cogni...</td>\n",
       "      <td>...</td>\n",
       "      <td>Neutral</td>\n",
       "      <td>AUSTIN, Texas, Jan. 04, 2021 (GLOBE NEWSWIRE) ...</td>\n",
       "      <td>- Patients’ Cognition Improved 1.6 Points on A...</td>\n",
       "      <td>AUSTIN, Texas, March 08, 2021 (GLOBE NEWSWIRE)...</td>\n",
       "      <td>AUSTIN, Texas, April 26, 2021 (GLOBE NEWSWIRE)...</td>\n",
       "      <td>- Randomized, Controlled Study is Designed to ...</td>\n",
       "      <td>AUSTIN, Texas, June 17, 2021 (GLOBE NEWSWIRE) ...</td>\n",
       "      <td>AUSTIN, Texas, July 26, 2021 (GLOBE NEWSWIRE) ...</td>\n",
       "      <td>AUSTIN, Texas, Aug. 03, 2021 (GLOBE NEWSWIRE) ...</td>\n",
       "      <td>AUSTIN, Texas, Sept. 09, 2021 (GLOBE NEWSWIRE)...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>surf</td>\n",
       "      <td>Surface Oncology to Participate in the H.C. Wa...</td>\n",
       "      <td>Surface Oncology to Report SRF388 Preclinical ...</td>\n",
       "      <td>Surface Oncology Announces SRF617 and SRF388 W...</td>\n",
       "      <td>Surface Oncology Announces Exclusive License A...</td>\n",
       "      <td>Surface Oncology to Participate in H.C. Wainwr...</td>\n",
       "      <td>Surface Oncology to Appoint Robert Ross, M.D.,...</td>\n",
       "      <td>Surface Oncology to Collaborate with Merck on ...</td>\n",
       "      <td>Surface Oncology Presents Promising Preclinica...</td>\n",
       "      <td>Surface Oncology Reports Financial Results and...</td>\n",
       "      <td>...</td>\n",
       "      <td>GSK will have exclusive rights to develop and ...</td>\n",
       "      <td>CAMBRIDGE, Mass., Jan. 11, 2021 (GLOBE NEWSWIR...</td>\n",
       "      <td>Experienced clinical development executive to ...</td>\n",
       "      <td>CAMBRIDGE, Mass., March 09, 2021 (GLOBE NEWSWI...</td>\n",
       "      <td>CAMBRIDGE, Mass., April 09, 2021 (GLOBE NEWSWI...</td>\n",
       "      <td>CAMBRIDGE, Mass., May 05, 2021 (GLOBE NEWSWIRE...</td>\n",
       "      <td>Preliminary Data for SRF617 Show Good Tolerabi...</td>\n",
       "      <td>CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIR...</td>\n",
       "      <td>SRF388, a First-in-Class Anti-IL-27 Antibody, ...</td>\n",
       "      <td>Neutral</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>crdf</td>\n",
       "      <td>Cardiff Oncology to Present Data Further Demon...</td>\n",
       "      <td>Cardiff Oncology Presents Positive Efficacy an...</td>\n",
       "      <td>Cardiff Oncology Announces Third Quarter 2020 ...</td>\n",
       "      <td>Cardiff Oncology Presents Data at ASH Demonstr...</td>\n",
       "      <td>Cardiff Oncology Presents Data that Continues ...</td>\n",
       "      <td>Cardiff Oncology Presents Phase 2 mCRPC Trial ...</td>\n",
       "      <td>Cardiff Oncology to Present at the Oppenheimer...</td>\n",
       "      <td>Cardiff Oncology Announces Onvansertib Phase 1...</td>\n",
       "      <td>Cardiff Oncology to Present at the Jefferies V...</td>\n",
       "      <td>...</td>\n",
       "      <td>SAN DIEGO, Dec. 6, 2020 /PRNewswire/ -- Cardif...</td>\n",
       "      <td>SAN DIEGO, Jan. 15, 2021 /PRNewswire/ -- Cardi...</td>\n",
       "      <td>SAN DIEGO, Feb. 11, 2021 /PRNewswire/ -- Cardi...</td>\n",
       "      <td>SAN DIEGO, March 11, 2021 /PRNewswire/ -- Card...</td>\n",
       "      <td>SAN DIEGO, April 12, 2021 /PRNewswire/ -- Card...</td>\n",
       "      <td>SAN DIEGO, May 20, 2021 /PRNewswire/ -- Cardif...</td>\n",
       "      <td>SAN DIEGO, June 8, 2021 /PRNewswire/ -- Cardif...</td>\n",
       "      <td>SAN DIEGO, July 12, 2021 /PRNewswire/ -- Cardi...</td>\n",
       "      <td>SAN DIEGO, Aug. 25, 2021 /PRNewswire/ -- Cardi...</td>\n",
       "      <td>SAN DIEGO, Sept. 8, 2021 /PRNewswire/ -- Cardi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>avxl</td>\n",
       "      <td>Anavex Life Sciences Announces Completion of A...</td>\n",
       "      <td>Anavex Life Sciences Announces Positive Result...</td>\n",
       "      <td>Proof of Concept Controlled Phase 2 Clinical T...</td>\n",
       "      <td>Anavex Life Sciences Announces ANAVEX®2-73 (Bl...</td>\n",
       "      <td>Anavex Life Sciences Receives Michael J. Fox F...</td>\n",
       "      <td>Anavex Life Sciences Reports Fiscal 2021 First...</td>\n",
       "      <td>Anavex Life Sciences Reports ANAVEX®2-73 (blar...</td>\n",
       "      <td>Anavex Life Sciences Reports the Results of Re...</td>\n",
       "      <td>Anavex Life Sciences Announces Participation a...</td>\n",
       "      <td>...</td>\n",
       "      <td>Primary safety, pharmacokinetics and secondary...</td>\n",
       "      <td>NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- An...</td>\n",
       "      <td>NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- An...</td>\n",
       "      <td>NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- A...</td>\n",
       "      <td>NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) -- A...</td>\n",
       "      <td>NEW YORK, May 07, 2021 (GLOBE NEWSWIRE) -- Ana...</td>\n",
       "      <td>ANAVEX®2-73 treatment resulted in significant ...</td>\n",
       "      <td>Pre-Treatment with ANAVEX®2-73 entirely preven...</td>\n",
       "      <td>NEW YORK, Aug. 12, 2021 (GLOBE NEWSWIRE) -- An...</td>\n",
       "      <td>NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- A...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>4 rows × 27 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "  Stock                                     Sep 2020_topic  \\\n",
       "0  sava  Cassava Sciences Announces Final Results of a ...   \n",
       "1  surf  Surface Oncology to Participate in the H.C. Wa...   \n",
       "2  crdf  Cardiff Oncology to Present Data Further Demon...   \n",
       "3  avxl  Anavex Life Sciences Announces Completion of A...   \n",
       "\n",
       "                                      Oct 2020_topic  \\\n",
       "0                                            Neutral   \n",
       "1  Surface Oncology to Report SRF388 Preclinical ...   \n",
       "2  Cardiff Oncology Presents Positive Efficacy an...   \n",
       "3  Anavex Life Sciences Announces Positive Result...   \n",
       "\n",
       "                                      Nov 2020_topic  \\\n",
       "0  USAN Modifies Lead Drug Candidate’s Chemical N...   \n",
       "1  Surface Oncology Announces SRF617 and SRF388 W...   \n",
       "2  Cardiff Oncology Announces Third Quarter 2020 ...   \n",
       "3  Proof of Concept Controlled Phase 2 Clinical T...   \n",
       "\n",
       "                                      Dec 2020_topic  \\\n",
       "0                                            Neutral   \n",
       "1  Surface Oncology Announces Exclusive License A...   \n",
       "2  Cardiff Oncology Presents Data at ASH Demonstr...   \n",
       "3  Anavex Life Sciences Announces ANAVEX®2-73 (Bl...   \n",
       "\n",
       "                                      Jan 2021_topic  \\\n",
       "0  Cassava Sciences Appoints Dr. James Kupiec as ...   \n",
       "1  Surface Oncology to Participate in H.C. Wainwr...   \n",
       "2  Cardiff Oncology Presents Data that Continues ...   \n",
       "3  Anavex Life Sciences Receives Michael J. Fox F...   \n",
       "\n",
       "                                      Feb 2021_topic  \\\n",
       "0  Cassava Sciences’ Simufilam Improves Cognition...   \n",
       "1  Surface Oncology to Appoint Robert Ross, M.D.,...   \n",
       "2  Cardiff Oncology Presents Phase 2 mCRPC Trial ...   \n",
       "3  Anavex Life Sciences Reports Fiscal 2021 First...   \n",
       "\n",
       "                                      Mar 2021_topic  \\\n",
       "0  Cassava Sciences to Present at the H.C. Wainwr...   \n",
       "1  Surface Oncology to Collaborate with Merck on ...   \n",
       "2  Cardiff Oncology to Present at the Oppenheimer...   \n",
       "3  Anavex Life Sciences Reports ANAVEX®2-73 (blar...   \n",
       "\n",
       "                                      Apr 2021_topic  \\\n",
       "0  Cassava Sciences Invited by the NIH to Partici...   \n",
       "1  Surface Oncology Presents Promising Preclinica...   \n",
       "2  Cardiff Oncology Announces Onvansertib Phase 1...   \n",
       "3  Anavex Life Sciences Reports the Results of Re...   \n",
       "\n",
       "                                      May 2021_topic  ...  \\\n",
       "0  Cassava Sciences Announces Initiation of Cogni...  ...   \n",
       "1  Surface Oncology Reports Financial Results and...  ...   \n",
       "2  Cardiff Oncology to Present at the Jefferies V...  ...   \n",
       "3  Anavex Life Sciences Announces Participation a...  ...   \n",
       "\n",
       "                                    Dec 2020_content  \\\n",
       "0                                            Neutral   \n",
       "1  GSK will have exclusive rights to develop and ...   \n",
       "2  SAN DIEGO, Dec. 6, 2020 /PRNewswire/ -- Cardif...   \n",
       "3  Primary safety, pharmacokinetics and secondary...   \n",
       "\n",
       "                                    Jan 2021_content  \\\n",
       "0  AUSTIN, Texas, Jan. 04, 2021 (GLOBE NEWSWIRE) ...   \n",
       "1  CAMBRIDGE, Mass., Jan. 11, 2021 (GLOBE NEWSWIR...   \n",
       "2  SAN DIEGO, Jan. 15, 2021 /PRNewswire/ -- Cardi...   \n",
       "3  NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- An...   \n",
       "\n",
       "                                    Feb 2021_content  \\\n",
       "0  - Patients’ Cognition Improved 1.6 Points on A...   \n",
       "1  Experienced clinical development executive to ...   \n",
       "2  SAN DIEGO, Feb. 11, 2021 /PRNewswire/ -- Cardi...   \n",
       "3  NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- An...   \n",
       "\n",
       "                                    Mar 2021_content  \\\n",
       "0  AUSTIN, Texas, March 08, 2021 (GLOBE NEWSWIRE)...   \n",
       "1  CAMBRIDGE, Mass., March 09, 2021 (GLOBE NEWSWI...   \n",
       "2  SAN DIEGO, March 11, 2021 /PRNewswire/ -- Card...   \n",
       "3  NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- A...   \n",
       "\n",
       "                                    Apr 2021_content  \\\n",
       "0  AUSTIN, Texas, April 26, 2021 (GLOBE NEWSWIRE)...   \n",
       "1  CAMBRIDGE, Mass., April 09, 2021 (GLOBE NEWSWI...   \n",
       "2  SAN DIEGO, April 12, 2021 /PRNewswire/ -- Card...   \n",
       "3  NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) -- A...   \n",
       "\n",
       "                                    May 2021_content  \\\n",
       "0  - Randomized, Controlled Study is Designed to ...   \n",
       "1  CAMBRIDGE, Mass., May 05, 2021 (GLOBE NEWSWIRE...   \n",
       "2  SAN DIEGO, May 20, 2021 /PRNewswire/ -- Cardif...   \n",
       "3  NEW YORK, May 07, 2021 (GLOBE NEWSWIRE) -- Ana...   \n",
       "\n",
       "                                    Jun 2021_content  \\\n",
       "0  AUSTIN, Texas, June 17, 2021 (GLOBE NEWSWIRE) ...   \n",
       "1  Preliminary Data for SRF617 Show Good Tolerabi...   \n",
       "2  SAN DIEGO, June 8, 2021 /PRNewswire/ -- Cardif...   \n",
       "3  ANAVEX®2-73 treatment resulted in significant ...   \n",
       "\n",
       "                                    Jul 2021_content  \\\n",
       "0  AUSTIN, Texas, July 26, 2021 (GLOBE NEWSWIRE) ...   \n",
       "1  CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIR...   \n",
       "2  SAN DIEGO, July 12, 2021 /PRNewswire/ -- Cardi...   \n",
       "3  Pre-Treatment with ANAVEX®2-73 entirely preven...   \n",
       "\n",
       "                                    Aug 2021_content  \\\n",
       "0  AUSTIN, Texas, Aug. 03, 2021 (GLOBE NEWSWIRE) ...   \n",
       "1  SRF388, a First-in-Class Anti-IL-27 Antibody, ...   \n",
       "2  SAN DIEGO, Aug. 25, 2021 /PRNewswire/ -- Cardi...   \n",
       "3  NEW YORK, Aug. 12, 2021 (GLOBE NEWSWIRE) -- An...   \n",
       "\n",
       "                                    Sep 2021_content  \n",
       "0  AUSTIN, Texas, Sept. 09, 2021 (GLOBE NEWSWIRE)...  \n",
       "1                                            Neutral  \n",
       "2  SAN DIEGO, Sept. 8, 2021 /PRNewswire/ -- Cardi...  \n",
       "3  NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- A...  \n",
       "\n",
       "[4 rows x 27 columns]"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = df_topic.merge(df_content, on ='Stock')\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "7261b780",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Apr 2021_content</th>\n",
       "      <th>Apr 2021_topic</th>\n",
       "      <th>Aug 2021_content</th>\n",
       "      <th>Aug 2021_topic</th>\n",
       "      <th>Dec 2020_content</th>\n",
       "      <th>Dec 2020_topic</th>\n",
       "      <th>Feb 2021_content</th>\n",
       "      <th>Feb 2021_topic</th>\n",
       "      <th>Jan 2021_content</th>\n",
       "      <th>Jan 2021_topic</th>\n",
       "      <th>...</th>\n",
       "      <th>May 2021_content</th>\n",
       "      <th>May 2021_topic</th>\n",
       "      <th>Nov 2020_content</th>\n",
       "      <th>Nov 2020_topic</th>\n",
       "      <th>Oct 2020_content</th>\n",
       "      <th>Oct 2020_topic</th>\n",
       "      <th>Sep 2020_content</th>\n",
       "      <th>Sep 2020_topic</th>\n",
       "      <th>Sep 2021_content</th>\n",
       "      <th>Sep 2021_topic</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Stock</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>sava</th>\n",
       "      <td>AUSTIN, Texas, April 26, 2021 (GLOBE NEWSWIRE)...</td>\n",
       "      <td>Cassava Sciences Invited by the NIH to Partici...</td>\n",
       "      <td>AUSTIN, Texas, Aug. 03, 2021 (GLOBE NEWSWIRE) ...</td>\n",
       "      <td>Cassava Sciences Reports Second Quarter 2021 F...</td>\n",
       "      <td>Neutral</td>\n",
       "      <td>Neutral</td>\n",
       "      <td>- Patients’ Cognition Improved 1.6 Points on A...</td>\n",
       "      <td>Cassava Sciences’ Simufilam Improves Cognition...</td>\n",
       "      <td>AUSTIN, Texas, Jan. 04, 2021 (GLOBE NEWSWIRE) ...</td>\n",
       "      <td>Cassava Sciences Appoints Dr. James Kupiec as ...</td>\n",
       "      <td>...</td>\n",
       "      <td>- Randomized, Controlled Study is Designed to ...</td>\n",
       "      <td>Cassava Sciences Announces Initiation of Cogni...</td>\n",
       "      <td>AUSTIN, Texas, Nov. 27, 2020 (GLOBE NEWSWIRE) ...</td>\n",
       "      <td>USAN Modifies Lead Drug Candidate’s Chemical N...</td>\n",
       "      <td>Neutral</td>\n",
       "      <td>Neutral</td>\n",
       "      <td>Alzheimer’s Patients in Drug Groups Showed Sta...</td>\n",
       "      <td>Cassava Sciences Announces Final Results of a ...</td>\n",
       "      <td>AUSTIN, Texas, Sept. 09, 2021 (GLOBE NEWSWIRE)...</td>\n",
       "      <td>Cassava Sciences to Present at H.C. Wainwright...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>surf</th>\n",
       "      <td>CAMBRIDGE, Mass., April 09, 2021 (GLOBE NEWSWI...</td>\n",
       "      <td>Surface Oncology Presents Promising Preclinica...</td>\n",
       "      <td>SRF388, a First-in-Class Anti-IL-27 Antibody, ...</td>\n",
       "      <td>Surface Oncology Reports Financial Results and...</td>\n",
       "      <td>GSK will have exclusive rights to develop and ...</td>\n",
       "      <td>Surface Oncology Announces Exclusive License A...</td>\n",
       "      <td>Experienced clinical development executive to ...</td>\n",
       "      <td>Surface Oncology to Appoint Robert Ross, M.D.,...</td>\n",
       "      <td>CAMBRIDGE, Mass., Jan. 11, 2021 (GLOBE NEWSWIR...</td>\n",
       "      <td>Surface Oncology to Participate in H.C. Wainwr...</td>\n",
       "      <td>...</td>\n",
       "      <td>CAMBRIDGE, Mass., May 05, 2021 (GLOBE NEWSWIRE...</td>\n",
       "      <td>Surface Oncology Reports Financial Results and...</td>\n",
       "      <td>Both programs have successfully escalated to d...</td>\n",
       "      <td>Surface Oncology Announces SRF617 and SRF388 W...</td>\n",
       "      <td>CAMBRIDGE, Mass., Oct. 26, 2020 (GLOBE NEWSWIR...</td>\n",
       "      <td>Surface Oncology to Report SRF388 Preclinical ...</td>\n",
       "      <td>CAMBRIDGE, Mass., Sept. 11, 2020 (GLOBE NEWSWI...</td>\n",
       "      <td>Surface Oncology to Participate in the H.C. Wa...</td>\n",
       "      <td>Neutral</td>\n",
       "      <td>Neutral</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>crdf</th>\n",
       "      <td>SAN DIEGO, April 12, 2021 /PRNewswire/ -- Card...</td>\n",
       "      <td>Cardiff Oncology Announces Onvansertib Phase 1...</td>\n",
       "      <td>SAN DIEGO, Aug. 25, 2021 /PRNewswire/ -- Cardi...</td>\n",
       "      <td>Cardiff Oncology to Present New Data from Lead...</td>\n",
       "      <td>SAN DIEGO, Dec. 6, 2020 /PRNewswire/ -- Cardif...</td>\n",
       "      <td>Cardiff Oncology Presents Data at ASH Demonstr...</td>\n",
       "      <td>SAN DIEGO, Feb. 11, 2021 /PRNewswire/ -- Cardi...</td>\n",
       "      <td>Cardiff Oncology Presents Phase 2 mCRPC Trial ...</td>\n",
       "      <td>SAN DIEGO, Jan. 15, 2021 /PRNewswire/ -- Cardi...</td>\n",
       "      <td>Cardiff Oncology Presents Data that Continues ...</td>\n",
       "      <td>...</td>\n",
       "      <td>SAN DIEGO, May 20, 2021 /PRNewswire/ -- Cardif...</td>\n",
       "      <td>Cardiff Oncology to Present at the Jefferies V...</td>\n",
       "      <td>SAN DIEGO, Nov. 5, 2020 /PRNewswire/ -- Cardif...</td>\n",
       "      <td>Cardiff Oncology Announces Third Quarter 2020 ...</td>\n",
       "      <td>SAN DIEGO, Oct. 20, 2020 /PRNewswire/ -- Cardi...</td>\n",
       "      <td>Cardiff Oncology Presents Positive Efficacy an...</td>\n",
       "      <td>SAN DIEGO, Sept. 14, 2020 /PRNewswire/ -- Card...</td>\n",
       "      <td>Cardiff Oncology to Present Data Further Demon...</td>\n",
       "      <td>SAN DIEGO, Sept. 8, 2021 /PRNewswire/ -- Cardi...</td>\n",
       "      <td>Cardiff Oncology Announces New Data from Phase...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avxl</th>\n",
       "      <td>NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) -- A...</td>\n",
       "      <td>Anavex Life Sciences Reports the Results of Re...</td>\n",
       "      <td>NEW YORK, Aug. 12, 2021 (GLOBE NEWSWIRE) -- An...</td>\n",
       "      <td>Anavex Life Sciences Provides Business Update ...</td>\n",
       "      <td>Primary safety, pharmacokinetics and secondary...</td>\n",
       "      <td>Anavex Life Sciences Announces ANAVEX®2-73 (Bl...</td>\n",
       "      <td>NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- An...</td>\n",
       "      <td>Anavex Life Sciences Reports Fiscal 2021 First...</td>\n",
       "      <td>NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- An...</td>\n",
       "      <td>Anavex Life Sciences Receives Michael J. Fox F...</td>\n",
       "      <td>...</td>\n",
       "      <td>NEW YORK, May 07, 2021 (GLOBE NEWSWIRE) -- Ana...</td>\n",
       "      <td>Anavex Life Sciences Announces Participation a...</td>\n",
       "      <td>Statistically significant improvements in CDR ...</td>\n",
       "      <td>Proof of Concept Controlled Phase 2 Clinical T...</td>\n",
       "      <td>Clinically meaningful, dose-dependent, and sta...</td>\n",
       "      <td>Anavex Life Sciences Announces Positive Result...</td>\n",
       "      <td>NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- A...</td>\n",
       "      <td>Anavex Life Sciences Announces Completion of A...</td>\n",
       "      <td>NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- A...</td>\n",
       "      <td>Anavex Life Sciences to Present at the H.C. Wa...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>4 rows × 26 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        Apr 2021_content  \\\n",
       "Stock                                                      \n",
       "sava   AUSTIN, Texas, April 26, 2021 (GLOBE NEWSWIRE)...   \n",
       "surf   CAMBRIDGE, Mass., April 09, 2021 (GLOBE NEWSWI...   \n",
       "crdf   SAN DIEGO, April 12, 2021 /PRNewswire/ -- Card...   \n",
       "avxl   NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) -- A...   \n",
       "\n",
       "                                          Apr 2021_topic  \\\n",
       "Stock                                                      \n",
       "sava   Cassava Sciences Invited by the NIH to Partici...   \n",
       "surf   Surface Oncology Presents Promising Preclinica...   \n",
       "crdf   Cardiff Oncology Announces Onvansertib Phase 1...   \n",
       "avxl   Anavex Life Sciences Reports the Results of Re...   \n",
       "\n",
       "                                        Aug 2021_content  \\\n",
       "Stock                                                      \n",
       "sava   AUSTIN, Texas, Aug. 03, 2021 (GLOBE NEWSWIRE) ...   \n",
       "surf   SRF388, a First-in-Class Anti-IL-27 Antibody, ...   \n",
       "crdf   SAN DIEGO, Aug. 25, 2021 /PRNewswire/ -- Cardi...   \n",
       "avxl   NEW YORK, Aug. 12, 2021 (GLOBE NEWSWIRE) -- An...   \n",
       "\n",
       "                                          Aug 2021_topic  \\\n",
       "Stock                                                      \n",
       "sava   Cassava Sciences Reports Second Quarter 2021 F...   \n",
       "surf   Surface Oncology Reports Financial Results and...   \n",
       "crdf   Cardiff Oncology to Present New Data from Lead...   \n",
       "avxl   Anavex Life Sciences Provides Business Update ...   \n",
       "\n",
       "                                        Dec 2020_content  \\\n",
       "Stock                                                      \n",
       "sava                                             Neutral   \n",
       "surf   GSK will have exclusive rights to develop and ...   \n",
       "crdf   SAN DIEGO, Dec. 6, 2020 /PRNewswire/ -- Cardif...   \n",
       "avxl   Primary safety, pharmacokinetics and secondary...   \n",
       "\n",
       "                                          Dec 2020_topic  \\\n",
       "Stock                                                      \n",
       "sava                                             Neutral   \n",
       "surf   Surface Oncology Announces Exclusive License A...   \n",
       "crdf   Cardiff Oncology Presents Data at ASH Demonstr...   \n",
       "avxl   Anavex Life Sciences Announces ANAVEX®2-73 (Bl...   \n",
       "\n",
       "                                        Feb 2021_content  \\\n",
       "Stock                                                      \n",
       "sava   - Patients’ Cognition Improved 1.6 Points on A...   \n",
       "surf   Experienced clinical development executive to ...   \n",
       "crdf   SAN DIEGO, Feb. 11, 2021 /PRNewswire/ -- Cardi...   \n",
       "avxl   NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- An...   \n",
       "\n",
       "                                          Feb 2021_topic  \\\n",
       "Stock                                                      \n",
       "sava   Cassava Sciences’ Simufilam Improves Cognition...   \n",
       "surf   Surface Oncology to Appoint Robert Ross, M.D.,...   \n",
       "crdf   Cardiff Oncology Presents Phase 2 mCRPC Trial ...   \n",
       "avxl   Anavex Life Sciences Reports Fiscal 2021 First...   \n",
       "\n",
       "                                        Jan 2021_content  \\\n",
       "Stock                                                      \n",
       "sava   AUSTIN, Texas, Jan. 04, 2021 (GLOBE NEWSWIRE) ...   \n",
       "surf   CAMBRIDGE, Mass., Jan. 11, 2021 (GLOBE NEWSWIR...   \n",
       "crdf   SAN DIEGO, Jan. 15, 2021 /PRNewswire/ -- Cardi...   \n",
       "avxl   NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- An...   \n",
       "\n",
       "                                          Jan 2021_topic  ...  \\\n",
       "Stock                                                     ...   \n",
       "sava   Cassava Sciences Appoints Dr. James Kupiec as ...  ...   \n",
       "surf   Surface Oncology to Participate in H.C. Wainwr...  ...   \n",
       "crdf   Cardiff Oncology Presents Data that Continues ...  ...   \n",
       "avxl   Anavex Life Sciences Receives Michael J. Fox F...  ...   \n",
       "\n",
       "                                        May 2021_content  \\\n",
       "Stock                                                      \n",
       "sava   - Randomized, Controlled Study is Designed to ...   \n",
       "surf   CAMBRIDGE, Mass., May 05, 2021 (GLOBE NEWSWIRE...   \n",
       "crdf   SAN DIEGO, May 20, 2021 /PRNewswire/ -- Cardif...   \n",
       "avxl   NEW YORK, May 07, 2021 (GLOBE NEWSWIRE) -- Ana...   \n",
       "\n",
       "                                          May 2021_topic  \\\n",
       "Stock                                                      \n",
       "sava   Cassava Sciences Announces Initiation of Cogni...   \n",
       "surf   Surface Oncology Reports Financial Results and...   \n",
       "crdf   Cardiff Oncology to Present at the Jefferies V...   \n",
       "avxl   Anavex Life Sciences Announces Participation a...   \n",
       "\n",
       "                                        Nov 2020_content  \\\n",
       "Stock                                                      \n",
       "sava   AUSTIN, Texas, Nov. 27, 2020 (GLOBE NEWSWIRE) ...   \n",
       "surf   Both programs have successfully escalated to d...   \n",
       "crdf   SAN DIEGO, Nov. 5, 2020 /PRNewswire/ -- Cardif...   \n",
       "avxl   Statistically significant improvements in CDR ...   \n",
       "\n",
       "                                          Nov 2020_topic  \\\n",
       "Stock                                                      \n",
       "sava   USAN Modifies Lead Drug Candidate’s Chemical N...   \n",
       "surf   Surface Oncology Announces SRF617 and SRF388 W...   \n",
       "crdf   Cardiff Oncology Announces Third Quarter 2020 ...   \n",
       "avxl   Proof of Concept Controlled Phase 2 Clinical T...   \n",
       "\n",
       "                                        Oct 2020_content  \\\n",
       "Stock                                                      \n",
       "sava                                             Neutral   \n",
       "surf   CAMBRIDGE, Mass., Oct. 26, 2020 (GLOBE NEWSWIR...   \n",
       "crdf   SAN DIEGO, Oct. 20, 2020 /PRNewswire/ -- Cardi...   \n",
       "avxl   Clinically meaningful, dose-dependent, and sta...   \n",
       "\n",
       "                                          Oct 2020_topic  \\\n",
       "Stock                                                      \n",
       "sava                                             Neutral   \n",
       "surf   Surface Oncology to Report SRF388 Preclinical ...   \n",
       "crdf   Cardiff Oncology Presents Positive Efficacy an...   \n",
       "avxl   Anavex Life Sciences Announces Positive Result...   \n",
       "\n",
       "                                        Sep 2020_content  \\\n",
       "Stock                                                      \n",
       "sava   Alzheimer’s Patients in Drug Groups Showed Sta...   \n",
       "surf   CAMBRIDGE, Mass., Sept. 11, 2020 (GLOBE NEWSWI...   \n",
       "crdf   SAN DIEGO, Sept. 14, 2020 /PRNewswire/ -- Card...   \n",
       "avxl   NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- A...   \n",
       "\n",
       "                                          Sep 2020_topic  \\\n",
       "Stock                                                      \n",
       "sava   Cassava Sciences Announces Final Results of a ...   \n",
       "surf   Surface Oncology to Participate in the H.C. Wa...   \n",
       "crdf   Cardiff Oncology to Present Data Further Demon...   \n",
       "avxl   Anavex Life Sciences Announces Completion of A...   \n",
       "\n",
       "                                        Sep 2021_content  \\\n",
       "Stock                                                      \n",
       "sava   AUSTIN, Texas, Sept. 09, 2021 (GLOBE NEWSWIRE)...   \n",
       "surf                                             Neutral   \n",
       "crdf   SAN DIEGO, Sept. 8, 2021 /PRNewswire/ -- Cardi...   \n",
       "avxl   NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- A...   \n",
       "\n",
       "                                          Sep 2021_topic  \n",
       "Stock                                                     \n",
       "sava   Cassava Sciences to Present at H.C. Wainwright...  \n",
       "surf                                             Neutral  \n",
       "crdf   Cardiff Oncology Announces New Data from Phase...  \n",
       "avxl   Anavex Life Sciences to Present at the H.C. Wa...  \n",
       "\n",
       "[4 rows x 26 columns]"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = df.set_index('Stock')\n",
    "df = df.reindex(columns=sorted(df.columns))\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "b700882a",
   "metadata": {},
   "outputs": [],
   "source": [
    "# saving data\n",
    "df.to_csv('stock_reports.csv')"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
